Opinion

Video

Management of Comment Adverse Effects Associated with mCRPC Therapies

Key opinion leaders explore strategies for managing common side effects associated with metastatic castration-resistant prostate cancer (mCRPC) treatments, including androgen receptor-targeted therapies.

Related Videos
2 experts in this video
2 experts in this video
Vanita Gaglani, RPT, answers a question during a video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.